VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
COHR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
COHRCoherent, Inc.
$317.36$62.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCOHRBalance Sheet

Coherent, Inc. (COHR) Balance Sheet

30Y historyFree accessUpdated daily

The balance sheet has strengthened materially, with the debt-to-equity ratio improving to 0.31 and total equity expanding 43% to $10.9B, though the cash position has declined to $1.2B amidst aggressive capital investment.

Income StatementBalance SheetCash FlowRatios

COHR Balance Sheet

Annual statement

COHR Balance Sheet

Coherent, Inc. (COHR) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricJun'26Jun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97
Total Current Assets6.93B3.93B3.66B3.25B4.31B3.03B1.79B812.91M761.84M702.3M582.96M512.97M505.73M461.14M410.37M395.54M288.27M230.4M226.27M154.97M127.63M111.74M82.58M67.81M55.84M55.71M36.35M29M27.2M30.8M
Cash & Short-Term Investments1.99B909.2M926.03M821.31M2.58B1.59B493.05M204.87M247.04M271.89M218.44M173.63M174.66M185.43M134.94M149.46M108.03M95.93M72.83M32.62M26.89M21.68M21.68M15.58M9.61M8.09M6.33M5.6M4.2M10.9M
Cash Only1.16B909.2M926.03M821.31M2.58B1.59B493.05M204.87M247.04M271.89M218.44M173.63M174.66M185.43M134.94M149.46M108.03M95.93M69.83M32.62M26.89M21.68M21.68M15.58M9.61M8.09M6.33M5.6M4.2M10.9M
Short-Term Investments825M000000000000000003M00000000000
Accounts Receivable1.34B1.02B848.54M901.53M700.33M658.96M598.12M269.64M215.03M193.38M164.82M140.77M136.72M111.72M113.25M99.21M78.62M43.11M55.87M44.96M42.12M35.98M26.09M22.09M21.54M21.88M14.2M13.1M11M10.8M
Days Sales Outstanding239.764.0765.7963.7777.0777.4491.7372.2367.7372.6172.7269.2573.0473.9980.0572.0283.1653.8564.4962.3666.1267.6963.1362.8869.1664.7669.9677.165.574.8
Inventory2.58B1.44B1.29B1.27B902.56M695.83M619.81M296.28M248.27M203.69M175.13M164.39M165.87M141.86M137.61M126.43M81.4M76.62M69.64M57.9M48.45M44.92M29.2M24.38M19.74M20.78M13.74M9.1M10.1M8.1M
Days Inventory Outstanding748.56139.83144.4137.57160.61131.7150.7128.57130.09127.38124.27127.56132.61148.98159.42155.95141.15165.86136.67147.01127.25155.2133.3128.23103.33105.09120.6890.78122.48121.17
Other Current Assets35.2M560.49M200.92M90.29M19.59M13.1M65.71M11.78M7.97M6.92M6.54M20.14M15.56M17.59M16.09M11.83M5.38M6.02M17.17M17.18M7.56M6.96M4.56M3.79M3.46M3.3M2.08M1.2M1.9M1M
Total Non-Current Assets11.37B10.98B10.83B10.46B3.54B3.49B3.45B1.14B999.82M775M629.02M545.2M566.2M402.66M296.11M251.66M220.71M137.97M134.66M136.01M122.66M140.94M101.35M94.98M96.06M92.47M47.78M41.8M40.6M23.7M
Property, Plant & Equipment21.29B1.88B1.82B1.78B1.36B1.24B1.21B582.79M524.89M367.73M242.86M203.81M208.94M170.67M153.92M138.13M117.94M86.41M86.33M85.64M77.71M77.9M62.34M57.95M60.71M58.03M40.88M37M35.9M19.6M
Fixed Asset Turnover0.10x3.09x2.59x2.90x2.43x2.50x1.96x2.34x2.21x2.64x3.41x3.64x3.27x3.23x3.36x3.64x2.93x3.38x3.66x3.07x2.99x2.49x2.42x2.21x1.87x2.13x1.81x1.68x1.71x2.69x
Goodwill4.38B4.47B4.46B4.51B1.29B1.3B1.24B319.78M270.68M250.34M233.75M195.89M196.15M123.35M80.75M64.26M56.09M26.14M26.53M24.49M23.29M000000000
Intangible Assets2.88B3.2B3.5B3.81B635.4M718.46M758.37M139.32M125.07M133.96M124.59M122.46M136.4M86.7M44.01M28.73M25M12.27M13.27M13.92M14.97M55.87M34.84M33.63M32.22M33.32M3.31M000
Long-Term Investments00000073.77M76.21M69.22M11.73M11.35M11.91M11.59M11.2M10.66M15.46M15.27M9.55M000000000000
Other Non-Current Assets-17.17B1.38B1B311.97M223.58M193.66M136.89M14.24M7.93M8.22M8.61M8.9M9.08M8.03M6.63M5.07M3.39M3.6M8.53M11.88M6.69M7.17M4.18M3.39M3.13M1.11M3.58M4.8M4.7M4.1M
Total Assets18.3B14.91B14.49B13.71B7.84B6.51B5.23B1.95B1.76B1.48B1.21B1.06B1.07B863.8M706.49M647.2M508.98M368.28M360.93M287.92M250.3M252.68M183.93M162.79M151.9M148.17M87.74M70.8M67.8M54.5M
Asset Turnover0.11x0.39x0.32x0.38x0.42x0.48x0.45x0.70x0.66x0.66x0.68x0.70x0.64x0.64x0.73x0.78x0.68x0.79x0.88x0.91x0.93x0.77x0.82x0.79x0.75x0.83x0.84x0.88x0.90x0.97x
Asset Growth %22.73%2.91%5.67%74.78%20.46%24.41%167.93%10.91%19.25%21.89%14.54%-1.28%24.09%22.27%9.16%27.16%38.2%2.04%25.35%15.03%-0.94%37.37%12.99%7.17%2.52%68.89%23.92%4.42%24.4%23.3%
Total Current Liabilities2.85B1.79B1.34B1.08B1.27B729.59M672.89M270.56M236.47M184.95M171.24M139.16M135.06M94.43M83.73M90.97M73.19M32.06M46.52M44.33M45.03M37.88M36.35M27.61M20.09M21.73M12.02M11.4M13.8M9.7M
Accounts Payable1.91B846.98M631.55M405.31M434.92M294.49M268.77M104.46M89.77M65.54M53.8M45.27M45.77M23.62M29.42M25.07M21.35M9.24M16.41M13.81M9.54M10.07M8.34M6.12M3.97M5.71M3.73M1.9M2.8M3.2M
Days Payables Outstanding552.6282.3870.8943.8277.3955.7465.3545.3347.0440.9838.1735.1336.5924.834.0830.9237.0220.0132.2135.0725.0534.838.0632.1620.7828.8932.7318.9533.9547.87
Short-Term Debt7.9M188.31M73.77M74.84M403.21M62.05M69.25M23.83M20M20M20M20M20M003.73M00055K7.55M3.8M7.55M6.92M5.07M3.83M44K4.1M5.9M600K
Deferred Revenue (Current)062.97M62.12M104.48M22.96M13.93M17.33M10.39M3.38M2.35M4.01M8.77M4.32M00000002.57M000000000
Other Current Liabilities879.2M348.8M256.65M223.13M189.85M203.36M185.18M76.33M71M62.72M62.92M43.25M36.05M38.65M28.69M34.03M10.51M11.53M1.98M7.1M6.16M4.72M4.29M1.95M1.01M3.98M8.24M5.4M5.1M5.9M
Current Ratio2.43x2.19x2.72x3.01x3.40x4.15x2.66x3.00x3.22x3.80x3.40x3.69x3.74x4.88x4.90x4.35x3.94x7.19x4.86x3.50x2.83x2.95x2.27x2.46x2.78x2.56x3.03x2.54x1.97x3.18x
Quick Ratio1.52x1.39x1.77x1.84x2.69x3.20x1.74x1.91x2.17x2.70x2.38x2.50x2.52x3.38x3.26x2.96x2.83x4.80x3.37x2.19x1.76x1.76x1.47x1.57x1.80x1.61x1.88x1.75x1.24x2.34x
Cash Conversion Cycle435.64121.51139.3157.51160.29153.4177.08155.47150.78159.01158.82161.68169.06198.17205.38197.06187.29199.7168.95174.29168.31188.08158.37158.95151.71140.96157.91148.93154.02148.1
Total Non-Current Liabilities4.21B4.63B5.2B5.4B2.19B1.65B2.49B550M500.88M391.78M258.4M189.93M261.82M133.26M31.37M33.13M24.94M13.84M24.27M24.73M34.67M55.93M16.27M23.66M34.15M37.03M9.89M4.9M3.9M2.3M
Long-Term Debt3.21B3.5B4.03B4.23B1.9B1.31B2.19B443.16M419.01M322.02M215.31M155.96M221.96M114.04M12.77M15M3.38M3.67M3.79M14.94M23.61M41.18M7.99M16.78M29.43M33.17M5.54M2.5M2.3M700K
Capital Lease Obligations254.8M165.16M162.35M140.75M110.21M125.54M94.7M0023.41M00000000000000000000
Deferred Tax Liabilities540.6M711.72M784.37M780.31M77.26M73.96M45.55M23.91M27.24M15.35M11.1M7.11M7.44M4.09M5.88M6.64M10.72M1.95M5.21M5.5M8.12M10.74M6.18M5.58M4.71M3.86M3.12M2.4M1.6M1.6M
Other Non-Current Liabilities198.1M259.32M225.41M247.4M109.92M138.12M158.67M82.92M54.63M31M31.99M26.86M32.42M15.13M17.88M11.49M10.83M7.77M15.27M3.71M2.94M2.4M2.11M1.3M000000
Total Liabilities7.06B6.43B6.54B6.48B3.46B2.38B3.16B820.56M737.35M576.73M429.64M329.08M396.88M227.69M115.1M124.1M98.12M45.91M70.8M68.48M79.7M93.81M52.07M51.27M54.24M58.76M21.9M16.3M17.7M12M
Total Debt3.54B3.89B4.3B4.49B2.44B1.53B2.37B467M439.01M365.44M235.31M175.96M241.96M114.04M12.77M18.73M3.38M3.67M3.79M14.99M31.17M44.98M15.54M23.7M34.5M37.01M5.58M6.6M8.2M1.3M
Net Debt2.38B2.98B3.38B3.67B-144.16M-65.85M1.88B262.13M191.97M93.55M16.86M2.32M67.3M-71.4M-122.17M-130.73M-104.64M-92.27M-66.04M-17.62M4.28M23.31M-6.15M8.12M24.89M28.91M-745K1M4M-9.6M
Debt / Equity0.31x0.46x0.54x0.62x0.56x0.37x1.14x0.41x0.43x0.41x0.30x0.24x0.36x0.18x0.02x0.04x0.01x0.01x0.01x0.07x0.18x0.28x0.12x0.21x0.35x0.41x0.09x0.12x0.16x0.03x
Debt / EBITDA11.07x3.53x6.30x4.67x3.48x2.27x6.82x1.94x2.02x2.04x1.58x1.35x2.43x1.02x0.11x0.15x0.05x0.06x0.05x0.23x0.57x1.00x0.47x0.89x1.71x1.37x0.36x0.51x0.60x0.10x
Net Debt / EBITDA7.44x2.71x4.95x3.81x-0.21x-0.10x5.41x1.09x0.88x0.52x0.11x0.02x0.68x-0.64x-1.05x-1.03x-1.44x-1.49x-0.86x-0.27x0.08x0.52x-0.18x0.31x1.23x1.07x-0.05x0.08x0.29x-0.76x
Interest Coverage7.78x2.27x0.49x-0.24x3.32x6.89x1.42x6.75x7.66x18.45x30.20x21.48x11.19x67.80x418.35x988.98x590.85x261.21x--1.18x76.75x56.93x11.92x5.02x3.59x21.48x41.20x32.33x-
Total Equity11.24B8.48B7.95B7.23B4.38B4.13B2.08B1.13B1.02B900.56M782.34M729.08M675.04M636.11M586.23M523.1M410.86M322.87M290.13M219.44M170.59M160.47M131.87M111.52M97.66M89.41M63.45M54.5M50.1M42.5M
Equity Growth %32.51%6.73%9.92%64.92%6.07%98.98%83.27%10.63%13.74%15.11%7.3%8.01%6.12%8.51%12.07%27.32%27.25%11.29%32.21%28.64%6.31%21.69%18.24%14.19%9.22%40.92%16.42%8.78%17.88%23.55%
Book Value per Share55.5854.7952.4252.5437.6235.9224.4817.2215.7313.9612.4411.6510.609.969.118.226.685.374.763.622.842.692.241.821.711.601.191.080.940.81
Total Shareholders' Equity10.9B8.13B7.57B7.23B4.38B4.13B2.08B1.13B1.02B900.56M782.34M729.08M675.04M636.11M586.23M522.37M410.35M322.38M290.13M219.44M170.59M160.47M131.87M111.52M97.66M89.41M63.45M54.5M50.1M42.5M
Common Stock9.79B5.06B4.86B3.78B2.06B2.03B1.49B382.42M351.76M269.64M243.81M226.61M213.57M194.28M176.29M159.19M000057.43M52.41M42.43M39.43M37.84M37.05M20.45M18.7M00
Retained Earnings1.35B584.37M664.94M944.42M1.35B1.14B876.55M943.58M836.06M748.06M652.79M587.3M521.33M482.88M434.94M378.37M295.68M257.11M220.32M158.29M120.32M115.11M90.27M73.07M61.45M54.19M44.83M37.4M31.9M25.1M
Treasury Stock-445.48M-368.06M-315.12M-293.12M-239.35M-218.47M-199.31M-168.57M-159.73M-103.36M-100.25M-93.5M-79.26M-56.65M-35.25M-28.29M-28.65M-28.29M-15.36M-8.46M-7.9M-2.09M-1.91M-1.91M-1.91M-1.91M-1.91M-1.9M00
Accumulated OCI204.11M372.04M2.64M109.73M-2.17M14.27M-87.38M-24.22M-3.78M-13.78M-14.02M8.66M19.41M15.6M10.24M13.12M4.01M3.86M3.58M939K742K631K1.08M930K279K91K2.46M300K-20.5M-17.2M
Minority Interest334.7M353.51M371.39M000000000001.43M727K507K0000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Massive CapEx consuming cash flow

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Leverage Easing Amidst Asset Expansion

The balance sheet has strengthened materially over the past year, with total equity expanding 43% from $7.6B in Q2 2025 to $10.9B in Q4 2026, while the debt-to-equity ratio has improved from 0.51 to 0.31, according to the company's quarterly filings.

This positive trajectory is driven by robust retained earnings growth, which has more than doubled from $730.1M to $1.4B over the same period, indicating the business is generating and retaining significant value. The simultaneous expansion of total assets from $14.2B to $18.3B, primarily through PPE growth, suggests the company is reinvesting its earnings into productive capacity to support the AI-driven growth cycle, rather than relying on debt financing.

Strategic Leverage with Manageable Profile

Coherent maintains a conservative leverage profile with a debt-to-equity ratio of 0.31 as of Q4 2026, down from 0.46 a year prior, and a current ratio of 2.43, suggesting the debt load is strategically managed and well-covered by liquid assets, based on the reported balance sheet.

The absolute debt level has been reduced from $4.3B in Q4 2024 to $3.5B in Q4 2026, indicating a deliberate deleveraging effort concurrent with the growth investment cycle. This prudent management appears to provide sufficient financial flexibility to fund the massive capital expenditure program without straining the balance sheet, though the absolute debt level remains significant relative to the company's cash position.

Asset-Light Shift Masked by Heavy Investment

The asset mix reveals a strategic pivot, with PPE net growing 67% from $1.8B to $3.0B over two years, while goodwill remains stable at ~$4.4B, indicating the current growth is being funded through internal reinvestment rather than acquisition, as shown in the company's financial statements.

The rapid expansion of PPE suggests a major investment in manufacturing capacity, likely for next-generation optical transceivers and SiC substrates, which aligns with the reported CapEx surge. However, the stable goodwill balance implies the company is not pursuing further M&A-driven growth at this time, focusing instead on organic expansion. This asset-heavy investment cycle increases operating leverage and could pressure returns on capital if the anticipated demand does not fully materialize.

Retained Earnings Fueling Organic Growth

Equity quality is improving, with retained earnings growing 92% from $744.8M in Q4 2024 to $1.4B in Q4 2026, indicating that the company's growth is being funded primarily through internally generated profits rather than shareholder dilution, according to the balance sheet data.

The strong growth in retained earnings, despite the massive investment cycle, underscores the underlying profitability of the business. This trend suggests the company is successfully converting its revenue growth into tangible book value, which provides a solid foundation for future expansion. The absence of significant equity issuance implies management is confident in the cash flow generation potential of the current investment cycle.

Adequate Liquidity Amidst Investment Drain

Liquidity remains adequate with a current ratio of 2.43 in Q4 2026, but the cash position has declined from $1.6B in Q3 2026 to $1.2B, suggesting the aggressive capital expenditure program is consuming available cash reserves, as reported in the quarterly balance sheets.

While the current ratio indicates a healthy buffer for short-term obligations, the declining cash balance warrants monitoring, especially given the negative free cash flow trend noted in the cash flow analysis. The company appears to be relying on its operating cash flow and existing cash reserves to fund the investment cycle, which may limit its financial flexibility if the cycle extends longer than anticipated or if there is an unexpected operational downturn.

Goodwill and PPE Quality Under Scrutiny

The balance sheet carries $4.4B in goodwill, representing 24% of total assets, which poses a potential impairment risk if the acquired businesses from the II-VI merger fail to meet performance expectations in the current cycle, based on the company's reported asset composition.

This significant goodwill balance is a legacy of the transformative acquisition and remains a non-cash asset that could be written down in a downturn, directly impacting equity. Furthermore, the rapid expansion of PPE to $3.0B raises questions about the quality and future utilization of these assets; if the AI-driven demand for optical transceivers normalizes, the company could face elevated depreciation charges and potential impairment on newly built capacity, masking the true economic return on this investment cycle.

COHR — Frequently Asked Questions

Quick answers to the most common questions about buying COHR stock.

What are the total assets of Coherent, Inc. (COHR)?

As of 2026, Coherent, Inc. (COHR) had total assets of $18.30B including $6.93B in current assets.

How much debt does Coherent, Inc. (COHR) have?

Coherent, Inc. (COHR) carries total debt of $3.54B, offset by $1.99B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Coherent, Inc.?

Coherent, Inc. (COHR) has total shareholders' equity (book value) of $10.90B ($55.58 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Coherent, Inc.'s current ratio and liquidity?

Coherent, Inc. (COHR) reported a current ratio of 2.43x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.